Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 2, 2015, Pages 161-170

  Gela, A ^a   Kasetty, G ^a   Jovic, S ^a   Ekoff, M ^b   Nilsson, G ^b   Morgelin M ^a   Kjellstrom S ^c   Pease, J E ^d   Schmidtchen, A ^a,e   Egesten, A ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

allergy; bacterial infection; eotaxins; host defense

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHYMASE; EOTAXIN 3; LIPOPOLYSACCHARIDE; PROTEINASE; SODIUM CHLORIDE; TRYPTASE; ANTIINFECTIVE AGENT; BETA CHEMOKINE; CCL26 PROTEIN, HUMAN; EOTAXIN; EOTAXIN 2; PEPTIDE HYDROLASE;

ALLERGIC ASTHMA; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONCENTRATION (PARAMETERS); ELECTRON MICROSCOPY; HOST RESISTANCE; INNATE IMMUNITY; MAST CELL; MEMBRANE DAMAGE; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUPERNATANT; AMINO ACID SEQUENCE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CHEMOKINE CCL11; CHEMOKINE CCL24; CHEMOKINES, CC; HUMANS; IMMUNITY, INNATE; MAST CELLS; MODELS, MOLECULAR; PEPTIDE HYDROLASES; PROTEIN CONFORMATION; RECEPTORS, CCR3; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84920854807     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12542     Document Type: Article

References (34)

1. Singh PK, Tack BF, McCray PB Jr, Welsh MJ,. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279: L799-L805.
2. Bals R, Wang X, Zasloff M, Wilson JM,. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541-9546.
3. Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102: 874-880.
4. Harder J, Bartels J, Christophers E, Schroder JM,. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-5713.
5. Kolls JK, McCray PB Jr, Chan YR,. Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 2008; 8: 829-835.
6. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM,. Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001; 167: 623-627.
7. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003; 74: 448-455.
8. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 2003; 170: 1452-1461.
9. Burkhardt AM, Tai KP, Flores-Guiterrez JP, Vilches-Cisneros N, Kamdar K, Barbosa-Quintana O, et al. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 2012; 188: 6399-6406.
10. Linge HM, Collin M, Nordenfelt P, Mörgelin M, Malmsten M, Egesten A,. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother 2008; 52: 2599-2607.
11. Pease JE, Williams TJ,. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 2006; 118: 305-318.
12. Crump MP, Rajarathnam K, Kim KS, Clark-Lewis I, Sykes BD,. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J Biol Chem 1998; 273: 22471-22479.
13. Pejler G, Rönnberg E, Waern I, Wernersson S,. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010; 115: 4981-4990.
14. Jounio U, Juvonen R, Bloigu A, Silvennoinen-Kassinen S, Kaijalainen T, Kauma H, et al. Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men. Clin Respir J 2010; 4: 222-229.
15. Zhang Q, Illing R, Hui CK, Downey K, Carr D, Stearn M, et al. Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respir Res 2012; 13: 35.
16. Pezzulo AA, Tang XX, Hoegger MJ, Alaiwa MH, Ramachandran S, Moninger TO, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012; 487: 109-113.
17. Boman HG,. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254: 197-215.
18. Gant VA, Warnes G, Phillips I, Savidge GF,. The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol 1993; 39: 147-154.
19. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC,. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-1297.
20. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM,. Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995; 182: 1301-1314.
21. Coleman JM, Naik C, Holguin F, Ray A, Ray P, Trudeau JB, et al. Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset. Thorax 2012; 67: 1061-1066.
22. Chen JH, Stoltz DA, Karp PH, Ernst SE, Pezzulo AA, Moninger TO, et al. Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell 2010; 143: 911-923.
23. Frick IM, Nordin SL, Baumgarten M, Mörgelin M, Sørensen OE, Olin AI, et al. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes. J Immunol 2011; 187: 4300-4309.
24. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005; 352: 2082-2090.
25. Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 2008; 122: 719-723.
26. Klemets P, Lyytikäinen O, Ruutu P, Ollgren J, Kaijalainen T, Leinonen M, et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010; 65: 698-702.
27. Beisswenger C, Kandler K, Hess C, Garn H, Felgentreff K, Wegmann M, et al. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol 2006; 177: 1833-1837.
28. Clement CG, Tuvim MJ, Evans CM, Tuvin DM, Dickey BF, Evans SE,. Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice. Respir Res 2009; 10: 70.
29. McKeever T, Harrison TW, Hubbard R, Shaw D,. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest 2013; 144: 1788-1794.
30. Provost V, Larose MC, Langlois A, Rola-Pleszczynski M, Flamand N, Laviolette M,. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. J Leukoc Biol 2013; 94: 213-222.
31. Michel O, Kips J, Duchateau J, Vertongen F, Robert L, Collet H, et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641-1646.
32. Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ,. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 2006; 176: 3788-3795.
33. Waern I, Lundequist A, Pejler G, Wernersson S,. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol 2013; 6: 911-920.
34. Rodriguez J, Gupta N, Smith RD, Pevzner PA,. Does trypsin cut before proline? J Proteome Res 2008; 7: 300-305.